Myriad Genetics (MYGN) Share-based Compensation Growth (5y) (2014 - 2026)
Myriad Genetics (MYGN) Share-based Compensation Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 296.09 Mn | 171.69 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.03% |
| Dec 31, 2025 | -28.42% |
| Sep 30, 2025 | 7.75% |
| Jun 30, 2025 | 2.62% |
| Mar 31, 2025 | 148.62% |
| Dec 31, 2024 | 83.65% |
| Sep 30, 2024 | 7.10% |
| Jun 30, 2024 | 10.50% |
| Mar 31, 2024 | 35.57% |
| Dec 31, 2023 | -59.33% |
| Sep 30, 2023 | 43.60% |
| Jun 30, 2023 | -7.90% |
| Mar 31, 2023 | 2.59% |
| Dec 31, 2022 | -20.08% |
| Sep 30, 2022 | 40.78% |
| Jun 30, 2022 | 21.27% |
| Mar 31, 2022 | 6.13% |
| Dec 31, 2021 | -33.35% |
| Sep 30, 2021 | 28.47% |
| Jun 30, 2021 | -58.05% |